New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

Journal Article New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening Get access Philip Skehan, Philip Skehan * Developmental Therapeutics Program, Division of Cancer Treatment * Correspondence to: Philip Skehan, M.D., Developmental Therapeutics Program, Division of Cancer Treatment, Bldg. 560, Rm. 3260, National Cancer Institute, Frederick Cancer Research Facility, Frederick, MD 21701 Search for other works by this author on: Oxford Academic PubMed Google Scholar Ritsa Storeng, Ritsa Storeng Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar Dominic Scudiero, Dominic Scudiero Program Resources, Inc., National Cancer Institute, Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Anne Monks, Anne Monks Program Resources, Inc., National Cancer Institute, Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar James McMahon, James McMahon Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar David Vistica, David Vistica Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar Jonathan T. Warren, Jonathan T. Warren Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar Heidi Bokesch, Heidi Bokesch Program Resources, Inc., National Cancer Institute, Frederick Cancer Research FacilityFrederick, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar Susan Kenney, Susan Kenney Developmental Therapeutics Program, Division of Cancer Treatment Search for other works by this author on: Oxford Academic PubMed Google Scholar Michael R. Boyd Michael R. Boyd Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer InstituteBethesda, MD. Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 82, Issue 13, 4 July 1990, Pages 1107–1112, https://doi.org/10.1093/jnci/82.13.1107 Published: 04 July 1990 Article history Received: 05 September 1980 Revision received: 11 December 1989 Accepted: 15 March 1990 Published: 04 July 1990